Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Johnson

Showing results (41-50 of 164) with videos related to

Pageof 17
Sort By:
American Journal of Ophthalmology|December 1, 1995
Fluorescein labeling of tissue plasminogen activator for subretinal thrombolysisT E Schneiderman, M W Johnson
Retina (Philadelphia, Pa.)|November 4, 1998
Perfluorocarbon liquid manipulation of high-density intraocular foreign bodiesH A Sudhalkar, M W Johnson
Journal of Steroid Biochemistry|October 1, 1976
A radioimmunoassay for betamethazone. Preparation of a specific antiserum to betamethazone-3 (O-carboxymethyl) oxime-bovine serum albumin and evaluation of methodM W Johnson, E Youssefnejadian, I Craft
Southern Medical Journal|July 1, 1980
Outbreak of meningococcal disease in a familyI Brook, R Gorman, M W Johnson
Journal of Clinical Pharmacology|May 1, 1979
The structure and function of a clinical pharmacology consulting serviceR Spector, A Heller, M W Johnson
Retina (Philadelphia, Pa.)|January 1, 1991
Tissue plasminogen activator treatment of experimental subretinal hemorrhageM W Johnson, K R Olsen, E Hernandez
Journal of Biomechanics|January 1, 1980
Ceramic models for piezoelectricity in dry boneM W Johnson, W S Williams, D Gross
Arteriosclerosis, Thrombosis, and Vascular Biology|February 12, 1999
Quantitative trait locus analysis of plasma lipoprotein levels in an autoimmune mouse model : interactions between lipoprotein metabolism, autoimmune disease, and atherogenesisL Gu, M W Johnson, A J Lusis
Ophthalmology|April 1, 1992
Tissue plasminogen activator thrombolysis during surgical evacuation of experimental subretinal hemorrhageM W Johnson, K R Olsen, E Hernandez
Healthcare Management Forum|January 4, 1989
Hospital risk management: the second decadeW R Keddy, M W Johnson, W McKerrow
Pageof 17

Showing results (41-50 of 164) with videos related to

Sort By:
Pageof 17
American Journal of Ophthalmology|December 1, 1995
Fluorescein labeling of tissue plasminogen activator for subretinal thrombolysisT E Schneiderman, M W Johnson
Retina (Philadelphia, Pa.)|November 4, 1998
Perfluorocarbon liquid manipulation of high-density intraocular foreign bodiesH A Sudhalkar, M W Johnson
Journal of Steroid Biochemistry|October 1, 1976
A radioimmunoassay for betamethazone. Preparation of a specific antiserum to betamethazone-3 (O-carboxymethyl) oxime-bovine serum albumin and evaluation of methodM W Johnson, E Youssefnejadian, I Craft
Southern Medical Journal|July 1, 1980
Outbreak of meningococcal disease in a familyI Brook, R Gorman, M W Johnson
Journal of Clinical Pharmacology|May 1, 1979
The structure and function of a clinical pharmacology consulting serviceR Spector, A Heller, M W Johnson
Retina (Philadelphia, Pa.)|January 1, 1991
Tissue plasminogen activator treatment of experimental subretinal hemorrhageM W Johnson, K R Olsen, E Hernandez
Journal of Biomechanics|January 1, 1980
Ceramic models for piezoelectricity in dry boneM W Johnson, W S Williams, D Gross
Arteriosclerosis, Thrombosis, and Vascular Biology|February 12, 1999
Quantitative trait locus analysis of plasma lipoprotein levels in an autoimmune mouse model : interactions between lipoprotein metabolism, autoimmune disease, and atherogenesisL Gu, M W Johnson, A J Lusis
Ophthalmology|April 1, 1992
Tissue plasminogen activator thrombolysis during surgical evacuation of experimental subretinal hemorrhageM W Johnson, K R Olsen, E Hernandez
Healthcare Management Forum|January 4, 1989
Hospital risk management: the second decadeW R Keddy, M W Johnson, W McKerrow
Pageof 17